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Pulmonary surfactant is a mixture of lipids and proteins that covers alveolar surfaces and keeps alveoli from collapsing. Four
speciﬁc proteins have been identiﬁed in surfactant. Among them, two C-type lectins, surfactant proteins A and D (SP-A and SP-
D), are known to be implicated in host defense and regulation of inﬂammatory responses of the lung. These host defense lectins
are structurally characterized by N-terminal collagen-like domains and lectin domains and are called pulmonary collectins. They
preventdisseminationofinfectiousmicrobesbytheirbiologicalactivitiesincludingagglutinationandgrowthinhibition.Theyalso
promote clearance of microbes by enhancing phagocytosis in macrophages. In addition, they interact with the other pattern-
recognition molecules, including Toll-like receptors (TLRs) and TLR-associated molecules, CD14 and MD-2, and regulate inﬂam-
matory responses. Furthermore, recent studies have demonstrated that these collectins modulate functions of neutrophil-derived
innate immune molecules by interacting with them. These ﬁndings indicate that pulmonary collectins play critical roles in host
defense of the lung.
1.Introduction
The respiratory system is always exposed to ambient air that
contains signiﬁcant numbers of infectious microbes. The
innate immune system in respiratory mucosa is important
as a ﬁrst line of host defense against microbes. Once pattern-
recognition receptors sense the microbes, inﬂammatory res-
ponses are triggered immediately [1]. These inﬂammatory
responses should be regulated thoroughly to prevent tissue
injury caused by excess inﬂammation.
The surface of the respiratory tract is covered with
pulmonary surfactant which is known for its essential role in
reducing surface tension to keep alveoli from collapsing [2].
Pulmonary surfactant is a mixture of lipids (90%) and pro-
teins(10%)thatareproducedandsecretedbyalveolartypeII
cells. The majority of lipids contained in pulmonary sur-
factantarephospholipidsincludingphosphatidylcholineand
phosphatidylglycerol[3].Thesephospholipidsareimportant
for surfactant functions. For example, dipalmitoyl phos-
phatidylcholine is essential for lowering surface tension.
Furthermore,arecentstudyhassuggestedthatphosphatidyl-
glycerol and phosphatidylinositol are involved in regulation
of inﬂammatory responses [4]. Four speciﬁc surfactant pro-
teins(SPs),SP-A,SP-B,SP-C,andSP-D,havebeenidentiﬁed.
Hydrophobic proteins, SP-B and SP-C, are critical for the
biophysicalfunctionsofsurfactant[5].Hydrophilic proteins,
SP-A and SP-D, belong to the C-type lectin superfamily and
are called pulmonary collectins. The structure of pulmonary
collectins is characterized by four domains that consist of
an N-terminus involved in interchain disulﬁde bonding, a
collagen-like domain, a coiled coil neck domain and a lectin,
orcarbohydraterecognitiondomain(CRD),whichisalectin
domain. Each monomeric protein is assembled to form a
triple helix at the collagenous domain. These trimers are
furtheroligomerizedtoformabouquet-likeoctadecamerfor
SP-A and a cruciform dodecamer for SP-D. A subpopulation
of SP-D includes a multimerized oligomer consisting of SP-
D molecules associated at their N-terminus (Figure 1)[ 6].
In this paper, we focus on pulmonary collectins and discuss
their roles in innate immune responses of the lung.2 Journal of Biomedicine and Biotechnology
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Figure 1: Structural organization of pulmonary collectins. SP-A forms a bouquet-like octadecamer assembled from six trimers, while SP-D
forms a cruciform dodecamer assembled from four trimers. A subpopulation of SP-D forms a multimerized oligomer associated with their
N-termini.
2.MouseModel
Genetic elimination of pulmonary collectins in mice has
provided invaluable information regarding their impor-
tant roles in the innate immunity and maintenance of
pulmonary homeostasis. Although the SP-A-deﬁcient mice
exhibit no apparent pathological changes [7], SP-D-deﬁcient
mice show impaired surfactant lipid metabolism that results
in advanced alveolar proteinosis [8]. Deﬁciency of SP-D
also causes abnormal pulmonary structure similar to that in
emphysema [9]. These knockout mice are susceptible to bac-
terialandviralinfections.Deﬁciencyofpulmonarycollectins
causes slower clearance of microbes including Pseudomonas
aeruginosa[10,11],Mycoplasmapulmonis[12],Pneumocystis
carinii [13], Histoplasma capsulatum [14], Haemophilus
inﬂuenza [15], group B streptococcus [15, 16], respiratory
syncytial virus [17, 18], and inﬂuenza type A virus [19, 20].
The knockout mice also exhibit increased inﬂammation
after infection of P. aeruginosa, H. inﬂuenza,g r o u pB
streptococcus, and inﬂuenza type A virus [10, 15, 20]. These
observations clearly indicate that pulmonary collectins play
critical roles in host defense of the lung. In the following
sections, the roles of pulmonary collectins in innate immune
system will be described in detail.
3. DirectActions of Pulmonary
Collectins on Microbes
Pulmonary collectins directly interact with and agglutinate
various microbes including fungi, yeasts, bacteria, and virus-
es to prevent dissemination. These collectins bind to various
ligands existing on the surface of microbes. For exam-
ple, lipopolysaccharides (LPS) on Gram-negative bacteria,
lipoteichoic acid on Gram-positive bacteria, glycoprotein on
fungi, lipoarabinomannan on mycobacteria, phospholipids
on mycoplasma, and viral surface glycoproteins have been
identiﬁed as ligands for pulmonary collectins [21]. Among
these ligands, the binding of collectins to LPS is well charac-
terized. SP-A binds rough LPS and lipid A but not smooth
LPS [22, 23]. SP-D binds Re LPS through the neck domain,
and Rc LPS, core oligosaccharide of LPS and selective
mannose-rich smooth LPS through the CRD domain [6, 24,
25].AnalysisofthecrystalstructureofSP-Arevealsanexten-
sive hydrophobic surface, which contributes to diﬀerences
in binding speciﬁcity observed between this protein and SP-
D[ 26]. When binding to Mycobacterium avium, SP-A binds
lipid ligand on M. avium containing no saccharide, while SP-
D binds mannose-rich glycolipid, lipoarabinomannan [27].
These ﬁndings suggest that SP-A tends to bind more to
hydrophobic ligand than SP-D.
In addition to agglutination activity, pulmonary col-
lectins also exhibit direct inhibitory eﬀects on the growth
of some microbes such as Escherichia coli, Klebsiella pneu-
moniae, Enterobacter aerogenes, Legionella pneumophila, M.
avium,H.capsulatum,andMycoplasmapneumoniae.Incuba-
tion of E. coli with pulmonary collectins results in enhanced
chromosomal staining with propidium iodide (an imperme-
ant ﬂuorescent dye), indicating that both SP-A and SP-D
inhibit the growth of Gram-negative bacteria by increasing
membrane permeability [28]. These pulmonary collectins
also inhibit the growth of M. avium. Signiﬁcant eﬀect of
growth inhibition was observed when the bacteria were cul-
tured in the presence of SP-A. Diﬀerent from the case
against Gram-negative bacteria, both SP-A and SP-D did
not increase the membrane permeability of M. avium. When
M. avium cultured in the presence of pulmonary collectinsJournal of Biomedicine and Biotechnology 3
was observed under a scanning electron microscope, the
surfaces of the bacteria were covered with proteins. The cov-
ered bacteria were more frequently observed in the sam-
ple cultured with SP-A. Furthermore, SP-A dramatically
decreased nutrient uptake of the bacteria. These data infer
that pulmonary collectins inhibit the growth of M. avium
by forming a physical barrier around the bacterial surface to
restrict nutrient uptake [27].
The growth of Gram-negative bacteria was inhibited by
C-terminal fragments of pulmonary collectins, which agglu-
tinated the bacteria very weakly [28]. Furthermore, SP-A
stronglyinhibitedthegrowthofM.aviuminspiteofitsnegli-
gible agglutination activity against the bacteria [27]. Thus, it
is likely that agglutination and growth inhibition by pulmo-
nary collectins are independent activities.
4. Regulation of Phagocytosis by
PulmonaryCollectins
The lung collectins augment the uptake of particles and
pathogens by diﬀerent mechanisms. The ﬁrst mechanism by
which pulmonary collectins augment pathogen uptake is by
opsonization. For example, C1q receptor mediates the pha-
gocytosis of SP-A-opsonized Staphylococcus aureus (S.
aureus)b ym o n o c y t e s[ 29]. SP-A-opsonized S. aureus [30]
and SP-A-opsonized bacillus Calmette-Gu´ erin (BCG) [31]
are ingested by macrophage via SP-R210, which is a speciﬁc
receptor for SP-A [32]. Pulmonary collectins stimulate pha-
gocytosis of Pseudomonas aeruginosa (P. aeruginosa)b ya l v e -
olar macrophages [33, 34]. However, P. aeruginosa is likely
to escape from phagocytosis. Because P. aeruginosa elastase
degrades pulmonary collectins [35], P. aeruginosa elastase
protectsagainstSP-A-mediatedopsonizationofP. aeruginosa
by degradation of the SP-A [36].
The next mechanism by which pulmonary collectins
augment uptake of pathogens is by upregulating expression
of cell surface receptors. SP-A stimulates the phagocytosis of
Streptococcus pneumoniae (S. pneumonia) in the presence of
EDTA, a condition that prevents SP-A attachment to bac-
teria. Because SP-A increases cell surface localization of
scavenger receptor A (SR-A) of alveolar macrophages in a
casein kinase-2-dependent manner, SP-A facilitates the pha-
gocytosis of S. pneumoniae [37]. Pulmonary collectins
increase the cell surface localization of mannose receptor
(MR)onmacrophages,resultinginincreasedphagocytosisof
M. avium [38]. Similarly, SP-A upregulates the cell surface
localization of MR and augments the uptake of M. tuberculo-
sis [39].
The lung collectins also augment the uptake of mam-
malian cells. SP-A increases the phagocytosis of erythrocytes
opsonized with IgG and complement by monocyte-derived
phagocytosis [40], indicating that SP-A augments FcR- and
CR1-activity. Pulmonary collectins enhance the uptake of
apoptoticcellsbyinteractionwithcalreticulinandCD91[41,
42]. In contrast, pulmonary collectins inhibit phagocytosis
of alveolar macrophage through signal inhibitory regulatory
protein α (SIRPα)[ 43].
5. Pulmonary CollectinsRestrict the
Growth of IntracellularMicrobes
As described above, pulmonary collectins upregulate phago-
cytosis of M. tuberculosis, M. avium,a n dL. pneumophila.
These bacteria are intracellular pathogens that can replicate
within macrophages, and it is important to determine
whether the eﬀects of the collectins contribute to clearance
ofmicrobes,orpromotepathogensurvival.Recently,Sawada
et al. have reported interesting results that resolve this issue
(Figure 2)[44].Inthereport,intracellulargrowthofL.pneu-
mophila was signiﬁcantly inhibited in macrophages infected
in the presence of pulmonary collectins. Experiments using
the pH-sensitive dye-labeled bacteria revealed that L. pneu-
mophila associated with pulmonary collectins are more eﬃ-
ciently recruited to an acidic intracellular compartment after
they are taken up by macrophages. Consistent with these
results, L. pneumophila phagocytosed in the presence of col-
lectins showed increased colocalization with LAMP-1 as
detected by immunocytochemistry. These data clearly indi-
cate that pulmonary collectins inhibit intracellular growth of
L. pneumophila by promoting phagosome-lysosome fusion.
Similar results have also been reported by Ferguson et al.
using M. tuberculosis and SP-D [45]. Although detailed
mechanisms involved in promotion of phagosome-lysosome
fusion remain unclear, these data indicate that pulmonary
collectins play important roles in eliminating intracellular
pathogens.
6. Pulmonary CollectinsModulate
Inﬂammatory CellularResponses
Pulmonary collectins are able to function to enhance or
inhibit inﬂammatory responses depending upon the patho-
gen, the responding cell, and the cytokine milieu [2, 46, 47].
The molecular mechanisms for collectin engagement of both
anti-inﬂammatory and proinﬂammatory signaling processes
have been investigated. One mode of action of the pul-
monary collectins is through direct interactions with pattern
recognition receptors, including the Toll-like receptor (TLR)
family and the TLR-associated molecule, CD14 and MD-2
(Figure 3). SP-A binds to the extracellular domains of TLR2
and TLR4; MD-2 and CD14 [22, 48–50]. For example, SP-
A directly interacts with the extracellular TLR2 domain,
inhibits the binding of PGN and zymosan to TLR2, and
reduces PGN- and zymosan-induced NF-κB activation and
proinﬂammatory cytokine production [48, 49]. Similarly,
SP-A inhibits the binding of smooth LPS to the cell surface
of TLR4/MD-2-expressing HEK293 cells [50]. Because SP-A
does not directly bind to PGN, zymosan or smooth LPS,
the interaction of SP-A with TLR2 or TLR4/MD-2 complex
inhibits the recognition of non-SP-A ligands, resulting in
the downregulation of their signaling and inﬂammatory res-
ponses. On the other hand, SP-A does not attenuate the
inﬂammatory responses induced by rough LPS, which is an
SP-A ligand [22]. Taken together, SP-A modulates the cel-
lular inﬂammatory responses in a microbial ligand-speciﬁc
manner (Figure 3). SP-D has been shown to bind to the
extracellular domains of TLR2 and TLR4, and to MD-24 Journal of Biomedicine and Biotechnology
Eﬀector molecules
(protein/DNA)
Legionella
ER
Phagosome
maturation
Lysosome
Degradation
Nucleus
Pore-forming activity
Type IV secretion system
(Dot/Icm)
Inhibit pore-forming activity
Inhibit
intracellular growth
Facilitate phagosome
-lysosome fusion
Collectin’s activity
Legionella pathogenicity
Intracellular growth
Figure 2: Roles of pulmonary collectins in host defense against L. pneumophila. During infection, L. pneumophila secretes various eﬀector
molecules via type IV secretion system to manipulate the host cell immune responses. This results in pore-forming on host cell membrane.
The secreted eﬀector molecules enable L. pneumophila to bypass phagosomes-lysosome fusion and survive in characteristic vacuoles
consisted of ER-derived membrane. Pulmonary collectins protect macrophage membrane against pore-forming activity of L. pneumophila.
The collectins also attenuate intracellular growth of L. pneumophila in part by facilitating phagosomes-lysosome fusion.
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Figure 3: Pulmonary collectins modulate inﬂammation via TLRs. Association of SP-A with TLR2 or TLR4/MD-2 complex results in the
downregulation of inﬂammatory responses by inhibiting the recognition of non-SP-A ligands including smooth LPS, peptidoglycan, and
zymosan via TLRs. In contrast, SP-A dose not inhibit secretion of proinﬂammatory cytokines induced by rough LPS, which is an SP-A
ligand. Interaction of SP-D with TLR4/MD-2 complex inhibits proinﬂammatory cytokine production induced by both smooth and rough
LPS.
through its CRD [51–53]. Although rough LPS but not
smooth LPS is an SP-D ligand, SP-D inhibits cell surface
binding of both serotypes of LPS to TLR4/MD-2-expressing
HEK293cellsandattenuatesthebindingsofthesolubleform
of MD-2 to LPS. Moreover, SP-D inhibits both serotypes
of LPS-induced TNF-α secretion from alveolar macrophages
and NF-κB activation in TLR4/MD-2-expressing HEK293
cells. The inhibitory eﬀect of SP-D is dependent upon the
formation of cruciform structure and its multimer [53].
Thus, unlike SP-A, SP-D downregulates inﬂammatory cellJournal of Biomedicine and Biotechnology 5
responseselicitedbysmoothandroughserotypesofLPS[53]
(Figure 3).
Another mechanism of dual functions of pulmonary
collectins on inﬂammation is depending on binding orienta-
tion of pulmonary collectins to their receptors [54]. In the
absence of microbes, pulmonary collectins bind via their
CRD to SIRPα and prevent inﬂammation. Because the inter-
action induces the activation of tyrosine phosphatase SHP-1,
resulting in blockage of the downstream signaling through
src-family kinases and p38 mitogen-activated protein (MAP)
kinase [54]. Hence, proinﬂammatory cytokine production is
attenuated by the CRD domain of the pulmonary collectins.
In contrast, the collagenous tail of SP-A mediates immunos-
timulatory eﬀects through binding to calreticulin/CD91
complex. When microbe or cell debris interact with the CRD
domain of SP-A, the collagenous domain of SP-A can engage
calreticulin/CD91 to stimulate p38 phosphorylation, NF-
κB activation, and cytokine production. Calreticulin/CD91
is not only an SP-A receptor but also a receptor for S-
nitrosylatedSP-D(SNO-SP-D)[55].S-nitrosylationdisrupts
dodecameric structure of SP-D and bares collagenous tail.
The binding of collagenous tail of SNO-SP-D to calretic-
ulin activates p38 phosphorylation, NF-κB activation and
cytokine production [55].
In conclusion, pulmonary collectins modulate inﬂam-
matory cellular responses. The distinct eﬀects of pulmonary
collectins on inﬂammation depend on the diﬀerent binding
speciﬁcities and orientations against various stimulators and
cell surface receptors.
7. InteractionbetweenPulmonary Collectins
andOther Host Defense Molecules
In addition to TLRs, MD-2, and CD14, pulmonary collectins
interact with additional host defense molecules and modu-
late innate immune reactions. SP-D has recently been shown
to interact with human α-defensins 1 and 2 [56, 57]. Human
α-defensinsareneutrophil-derivedpeptidesthatexhibitwide
spectrum antimicrobial activity against bacteria, fungi, and
viruses. While human α-defensins broadly neutralize multi-
ple strains of inﬂuenza A virus, the neutralizing eﬀects of SP-
D are dependent on the strain of the virus. SP-D binds to the
mannose-rich sugar chain on hemagglutinin and neutralizes
virus infectivity. The level of glycosylation on the globular
head of hemagglutinin seems to correlate with sensitivity to
SP-D[58].WhenSP-D-resistantstrainsweretreatedwithSP-
Dandα-defensin,theyexhibitedcooperativeantiviraleﬀects.
In contrast, competitive eﬀects were observed when using
SP-D-sensitive strains. In addition to the viral strain, the
sequence of incubation of a virus with α-defensins or SP-D
is responsible for diﬀerent eﬀects. These data indicate the
complex interaction between SP-D and α-defensins at sites
of infections [56, 57]. SP-D has also been shown to play
important roles in neutrophil extracellular trap-mediated
bacterial trapping [59]. Neutrophils generate DNA-based
extracellular traps to capture and kill microbes. SP-D binds
both the traps and microbial surfaces resulting in promotion
of bacterial trapping. These ﬁndings suggest that SP-D plays
importantrolesinneutrophils-mediatedhostdefenseagainst
microbes.
8.Perspectives
Both in vivo and in vitro studies have indicated the critical
roles of pulmonary collectins in host defense and mainte-
nance of homeostasis. Consistent with these results, several
human diseases have been reported to be associated with
polymorphisms in genes encoding pulmonary collectins and
concentrations of collectins in BALF or serum [60]. In ani-
malmodel,intratrachealadministrationofrecombinantpul-
monary collectins results in enhanced clearance of microbes
and regulation of inﬂammatory responses, suggesting the
possible usage of lung collectins as the basis of therapeutic
strategies. To date, a variety of functional recombinant pro-
teins including full-length proteins, C-terminal fragments,
and chimeric proteins have been prepared to characterize the
functions of pulmonary collectins. These recombinant pro-
teins are also candidates as therapeutic reagents. For exam-
ple, replacement of pulmonary collectins might be useful to
inhibit the growth of intracellular pathogens and eliminate
them, although detailed molecular basis of the inhibition
should be clariﬁed. Moreover, information about functions
of pulmonary collectins in physiological conditions, espe-
cially concerning interactions with other innate immune
molecules, should be accumulated to further advance the
possibility that collectins play roles as therapeutic reagents.
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